Carbohydrates and diet patterns in nonalcoholic fatty liver disease in children and adolescents

Curr Opin Clin Nutr Metab Care. 2018 Jul;21(4):283-288. doi: 10.1097/MCO.0000000000000476.

Abstract

Purpose of review: The primary treatment for nonalcoholic fatty liver disease (NAFLD) in children is lifestyle change, including a healthier diet. However, there are no agreed upon expert recommendations for a specific diet in the prevention or treatment of NAFLD. In this study, we review studies published between 2015 and 2017 contributing to further understanding of the role of diet in the development and progression of NAFLD, particularly those addressing sugars and dietary patterns.

Recent findings: Multiple recent studies have expanded on earlier evidence that suggests that high intake of sugars plays a causal role in the development of NAFLD, including several recent experimental studies in adults and children that support a unique effect of fructose consumption on liver fat accumulation. Evidence also points to protective effects of dietary patterns that include but are not limited to minimizing sugar intake, Dietary Approaches to Stop Hypertension (DASH), high protein and the Mediterranean diet. The effect of diet may act through its impact on the microbiome, and may be modified by presence or absence of genetic polymorphisms (nutrigenomics) and several new studies demonstrate this.

Summary: Diet appears to be a powerful tool in the prevention and treatment of NAFLD. It is imperative that researchers and clinicians continue to hone in on the mechanistic pathways and specific diets to reverse the growing morbidity and mortality of NAFLD.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Child
  • Diet, Healthy*
  • Dietary Carbohydrates / administration & dosage*
  • Dietary Carbohydrates / adverse effects
  • Dietary Sugars / administration & dosage
  • Dietary Sugars / adverse effects
  • Feeding Behavior
  • Fructose / administration & dosage*
  • Fructose / adverse effects
  • Gastrointestinal Microbiome
  • Humans
  • Lipid Metabolism / drug effects*
  • Lipogenesis / drug effects*
  • Liver / drug effects*
  • Liver / metabolism
  • Non-alcoholic Fatty Liver Disease / diet therapy*
  • Non-alcoholic Fatty Liver Disease / prevention & control
  • Polymorphism, Genetic

Substances

  • Dietary Carbohydrates
  • Dietary Sugars
  • Fructose